Population Based Cognitive Testing in Subjects with SARS-CoV-2

Population Based Cognitive Testing in Subjects with SARS-CoV-2 - POPCOV²

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023241

Enrollment

2600

Registered

2020-12-21

Start date

2020-12-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: Subjects with a positive COVID-19 test. We use two neuropsychological tests: The Montreal Cognitive Assessment (MoCA) and the Symbol Digital Modalities Test (SDMT). The examinations will be c

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Proof of an examination result for SARS-CoV-2 within the last week. • Understanding of the course of study and consent to study participation • Subject must be 18 years or older. • PC, smartphone or tablet must be available. • Willingness to conduct research on end-to-end encrypted video telephony.

Exclusion criteria

Exclusion criteria: <18 years of age

Design outcomes

Primary

Measure	Time frame
WHAT: Cognitive impairments in subjects with COVID-19 WHEN: Parameters are collected within one week after the test result, 4-6 weeks after the 1st test, 12-14 weeks after the 1st test In the case of pathological values, two further tests are carried out 24-26 weeks and 48-52 weeks after the 1st test HOW: The cognitive impairments are measured with the MoCA and the SDMT.	—

Countries

Germany

Contacts

Public ContactSaskia Elben

Universitätsklinikum Düsseldorf-Klinik für Neurologie Zentrum für Bewegungsstörungen und Neuromodulation

Saskia.Elben@med.uni-duesseldorf.de+49 (0)211-81-08503 / -08460

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026